
---
title: '复星医药、博瑞医药双双涨停开盘'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=8669'
author: 证券时报网
comments: false
date: Fri, 21 Jan 2022 09:31:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=8669'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688166" style="color: #2f67d1;text-decoration: none;" code="688166" target="_blank">博瑞医药</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600196" style="color: #2f67d1;text-decoration: none;" code="600196" target="_blank">复星医药</a>涨停开盘。消息面上，五家中国企业获授权，免费仿制默沙东口服新冠药，包括<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS600196" style="color: #2f67d1;text-decoration: none;" code="600196" target="_blank">复星医药</a>、<a class="trsHotWords" href="https://info.stcn.com/dc/stock/?stockcode=SS688166" style="color: #2f67d1;text-decoration: none;" code="688166" target="_blank">博瑞医药</a>。</p>

                  
</div>
            